Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca2+ dynamics
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-10336-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Pablo Shimaoka Chagas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do C…. Hauptthemen laut MEDLINE: Receptors, sigma, Mouth Neoplasms, Mitochondria, Calcium. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Fundação de Amparo a Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
BACKGROUND: Oral cancer is the most common malignancy of the oral cavity and facial region, affecting the mucosal and epithelial surfaces in the mouth and lips. Unfortunately, OC is often associated with a high mortality rate and limited treatment options for patients. METHODS AND RESULTS: Herein, we used in silico analysis and in vitro assays to investigate the impact of the Sigma-1 receptor (SIGMAR1) in OC progression by evaluating mitochondrial function, calcium signaling and clonogenic growth. First, the data from the TCGA pan-cancer analysis revealed that SIGMAR1 was overexpressed in OC versus healthy tissue and related to a worse survival rate. Furthermore, we demonstrated that SIGMAR1 silencing led to an increase in mitochondrial membrane potential, a reduction in cellular ATP levels, inhibition of Ca²⁺ influx, and a significant decrease in the clonogenic growth of OC cells. CONCLUSIONS: Based on these findings, we suggest that SIGMAR1 may influence mitochondrial membrane potential and energy production by modulating Ca2+ uptake, which is critically important to cellular survival. In addition, SIGMAR1 knockdown may offer a potential strategy to be further explored as treatment for OC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto, 14040-903, SP, Brazil. pablochagas@usp.br.
- Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, 30912, Augusta, GA, USA. pablochagas@usp.br.
- Department of Clinical Analyses, Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Av. do Café s/n, Ribeirão Preto, 14040-903, SP, Brazil.
- Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia, Augusta University, 30912, Augusta, GA, USA.
- Department of Surgery, Medical College of Georgia, Augusta University, 30912, Augusta, GA, USA.
Förderung
- Fundação de Amparo a Pesquisa do Estado de São Paulo
Zitieren
APA
Chagas, P. S., Garcia, C. B., Chagas, H. I. S., Yeudall, W. A., Yu, J. C., Baban, B., & Leopoldino, A. M. (2025). Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca2+ dynamics. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-10336-2
Vancouver
Chagas PS, Garcia CB, Chagas HIS, Yeudall WA, Yu JC, Baban B, et al. Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca2+ dynamics. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-10336-2
BibTeX
@article{Chagas2025,
author = {Chagas, Pablo Shimaoka and Garcia, Cristiana Bernadelli and Chagas, Henrique Izumi Shimaoka and Yeudall, W Andrew and Yu, Jack C and Baban, Babak and Leopoldino, Andréia Machado},
title = {Suppression of SIGMAR1 hinders oral cancer cell growth via modulation of mitochondrial Ca2+ dynamics},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-10336-2}
}
EUVIMED